Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01585129 · ClinicalTrials.gov registry record · Phase 4
Treatment Utility of Postpartum Antibiotics in Chorioamnionitis
A Phase 4 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT01585129 is a Phase 4 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 80 participants.
The verdict
NCT01585129, a Phase 4 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
To determine if prophylactic postpartum antibiotics are required post-cesarean delivery for pregnancies with treated chorioamnionitis.
Interventions
- DRUG Postpartum Antibiotics
- DRUG No postpartum antibiotics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2010-09 |
| Est. Completion | 2014-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01585129
The ClinicalTrials.gov registry entry for NCT01585129 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Postpartum Antibiotics is the first listed.
NCT01585129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01585129 about?
NCT01585129 is a clinical study titled "Treatment Utility of Postpartum Antibiotics in Chorioamnionitis". To determine if prophylactic postpartum antibiotics are required post-cesarean delivery for pregnancies with treated chorioamnionitis.
What is the current status of trial NCT01585129?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2010-09. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01585129?
The interventions under investigation include: Postpartum Antibiotics (DRUG), No postpartum antibiotics (DRUG).
Who is sponsoring clinical trial NCT01585129?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.